U.S. Court of Appeals for the Fifth Circuit (Willett, 2023-09-01: Fifth Circuit opinion reversing dismissal of three doctors' suit over FDA's anti-ivermectin messaging, holding the posts were reviewable agency action and that FDA may inform but not advise patients.
FDA is not a physician. It has authority to inform, announce, and apprise, but not to endorse, denounce, or advise.
24 (PDF p.24)
U.S. Court of Appeals for the Fifth Circuit (Willett, 2023-09-01: Fifth Circuit opinion reversing dismissal of three doctors' suit over FDA's anti-ivermectin messaging, holding the posts were reviewable agency action and that FDA may inform but not advise patients. C11 legal claim. Case: Robert L. Apter, Mary Talley Bowden and Paul E. Marik v. HHS, Becerra, FDA and Califf, No. 22-40802, on appeal from S.D. Tex. No. 3:22-CV-184. Holding: 'We REVERSE the district court's judgment of dismissal, and we REMAND for further proceedings' – the court did NOT rule that ivermectin works, and expressly left standing for the district court. The opinion opens by quoting the agency's 'You are not a horse' message and notes 'the human version of ivermectin is not FDA-approved to treat the coronavirus'. It also holds the posts lacked finality for the pure APA claim, so only the ultra vires claims proceed. Court document, public domain; the PDF is the court's own posted opinion.
